nach oben

World Journal of Urology

Erschienen in:

02.11.2023 | Topic Paper

Unmet needs in the management of neurourological disorders within the last 50 years

verfasst von: Amélie Bazinet, Emmanuel Chartier-Kastler

Erschienen in: World Journal of Urology | Ausgabe 12/2023

Einloggen, um Zugang zu erhalten

Abstract

Purpose

This abstract aims to assess the evolution of neurogenic patient management over the past century, with a focus on persistent unmet needs in the field. We reflect on the history of neurourology and its key principles, highlighting urgent needs for research and progress.

Methods

This review is based on a non-systematic search of MEDLINE databases. We explore the historical context, innovations, and challenges in neurological patient care, using keywords such as “Neurourology”, “history” and “future”, as well as specific treatment modalities.

Result

Several unmet needs in the field of neurourology have been identified. These include the need to strike a balance between spontaneous micturition and continence, the search for solutions to restore spontaneous micturition in patients with acontractile bladders, the imperative to improve and personalize renal and bladder function monitoring, mitigation of the side effects of long-term treatments, strategies to manage recurrent urinary tract infections, and efforts to overcome organizational barriers in patient care.

Conclusion

The care of neurological patients has made remarkable progress over the past 50 years. However, persistent unmet needs underline the need for ongoing research and collaboration to improve the quality of care in this field.

- Sanjay S, Hamid R (2020) Fifty years of ics: a brief history of neurourology. ICS News. https://www.ics.org/news/1140. (Accessed 11 Apr 2023)

Mattelaer JJ, Billiet I (1995) Catheters and sounds: the history of bladder catheterisation. Spinal Cord 33(8):429–433. https://doi.org/10.1038/sc.1995.95CrossRef

Gharbi M, Gazdovich S, Bazinet A, Cornu JN (2022) Quality of life in neurogenic patients based on different bladder management methods: a review. Prog Urol 32(11):784–808. https://doi.org/10.1016/j.purol.2022.07.004CrossRefPubMed

- Haute Autorité de Santé [HAS] (2014) Betmiga. https://www.has-sante.fr/upload/docs/evamed/CT-13270_BETMIGA_PIC_INS_Avispostaud_CT13270.pdf. (Accessed 13 Apr 2023)

- Food and Drug Administration [FDA] (2012) Myrbetriq. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/202611s011lbl.pdf. (Accessed 13 Apr 2023)

Zhang D, Sun F, Yao H, Bao X, Wang D, Cui Y et al (2021) The efficacy and safety of mirabegron for the treatment of neurogenic lower urinary tract dysfunction: a systematic review and meta-analysis. Front Pharmacol 12:756582. https://doi.org/10.3389/fphar.2021.756582CrossRefPubMedPubMedCentral

Akkoc Y (2022) Efficacy and safety of mirabegron for treatment of neurogenic detrusor overactivity in adults with spinal cord injury or multiple sclerosis: a systematic review. Spinal Cord 60(10):854–861. https://doi.org/10.1038/s41393-022-00853-3CrossRefPubMed

Longoria V, Parcel H, Toma B, Minhas A, Zeine R (2022) Neurological benefits, clinical challenges, and neuropathologic promise of medical marijuana: a systematic review of cannabinoid effects in multiple sclerosis and experimental models of demyelination. Biomedicines. https://doi.org/10.3390/biomedicines10030539CrossRefPubMedPubMedCentral

Michel MC (2020) Where will the next generation of medical treatments for overactive bladder syndrome come from? Int J Urol 27:289–294. https://doi.org/10.1111/iju.14189CrossRefPubMed

10.

Phé V, Chartier-Kastler E, Panicker JN (2016) Management of neurogenic bladder in patients with multiple sclerosis. Nat Rev Urol 13(5):275–288. https://doi.org/10.1038/nrurol.2016.53CrossRefPubMed

11.

Sartori AM, Kiss B, Mordasini L, Pollo C, Schüpbach M, Burkhard FC et al (2022) Effects of deep brain stimulation on lower urinary tract function in neurological patients. Eur Urol Focus 8(6):1775–1782. https://doi.org/10.1016/j.euf.2022.05.004CrossRefPubMed

12.

Guillot-Tantay C, Chartier-Kastler E, Mozer P, Bitker MO, Richard F, Ambrogi V, Denys P, Léon P, Phé V (2018) Male neurogenic stress urinary incontinence treated by artificial urinary sphincter AMS 800™ (Boston Scientific, Boston, USA): Very long-term results (>25 years). Prog Urol 28(1):39–47. https://doi.org/10.1016/j.purol.2017.09.012CrossRefPubMed

13.

Carson CC (2020) Artificial urinary sphincter: current status and future directions. Asian J Androl 22(2):154–157. https://doi.org/10.4103/aja.aja_5_20CrossRefPubMedPubMedCentral

14.

Moro C, Phelps C, Veer V, Clark J, Glasziou P, Tikkinen KAO, Scott AM (2022) The effectiveness of parasympathomimetics for treating underactive bladder: a systematic review and meta-analysis. Neurourol Urodyn 41(1):127–139. https://doi.org/10.1002/nau.24839CrossRefPubMed

15.

- Blok B, Castro-Díaz D, Del Popolo G, Groen J, Hamid R, Karsenty G et al (2022) European Association of Urology [EAU] Guidelines: Neuro-Urology. Edn. presented at the EAU Annual Congress Amsterdam 2022

16.

Guiho T, Azevedo-Coste C, Bauchet L, Delleci C, Vignes JR, Guiraud D, Fattal C (2022) Sacral anterior root stimulation and visceral function outcomes in spinal cord injury—a systematic review of the literature over four decades. World Neurosurg 157:218–232. https://doi.org/10.1016/j.wneu.2021.09.041. (e14)CrossRefPubMed

17.

Stenzl A, Ninkovic M, Kölle D, Knapp R, Anderl H, Bartsch G (1998) Restoration of voluntary emptying of the bladder by transplantation of innervated free skeletal muscle. Lancet 351(9114):1483–1485. https://doi.org/10.1016/S0140-6736(97)10005-8CrossRefPubMed

18.

Forte AJ, Boczar D, Huayllani MT, Moran S, Okanlami OO, Ninkovic M, Broer PN (2021) Latissimus dorsi detrusor myoplasty for bladder acontractility: a systematic review. Arch Plast Surg 48(5):528–533. https://doi.org/10.5999/aps.2021.00402CrossRefPubMedPubMedCentral

19.

Bayrak Ö, Dmochowski RR (2019) Underactive bladder: a review of the current treatment concepts. Turk J Urol 45(6):401–409. https://doi.org/10.5152/tud.2019.37659CrossRefPubMedPubMedCentral

20.

Hartigan SM, Dmochowski RR (2022) The inFlow intraurethral valve-pump for women with detrusor underactivity: a summary of peer-reviewed literature. J Spinal Cord Med 45(4):489–497. https://doi.org/10.1080/10790268.2020.1829415CrossRefPubMed

21.

Mingat N, Villar E, Allard J, Castel-Lacanal E, Guillotreau J, Malavaud B, Rischmann P, Tack I, Ruffion A, Gamé X (2013) Prospective study of methods of renal function evaluation in patients with neurogenic bladder dysfunction. Urology 82(5):1032–1037. https://doi.org/10.1016/j.urology.2013.07.027CrossRefPubMed

22.

Pavese C, Schneider MP, Schubert M, Curt A, Scivoletto G, Finazzi-Agrò E, Mehnert U, Maier D, Abel R, Röhrich F, Weidner N, Rupp R, Kessels AG, Bachmann LM, Kessler TM (2016) Prediction of bladder outcomes after traumatic spinal cord injury: a longitudinal cohort study. PLoS Med 13(6):e1002041. https://doi.org/10.1371/journal.pmed.1002041CrossRefPubMedPubMedCentral

23.

Wang W, Fang H, Xie P, Cao Q, He L, Cai W (2019) Create a predictive model for neurogenic bladder patients: upper urinary tract damage predictive nomogram. Int J Neurosci 129(12):1240–1246. https://doi.org/10.1080/00207454.2019.1655016CrossRefPubMed

24.

Dmochowski RR, Thai S, Iglay K, Enemchukwu E, Tee S, Varano S, Girman C, Radican L, Mudd PN Jr, Poole C (2021) Increased risk of incident dementia following use of anticholinergic agents: a systematic literature review and meta-analysis. Neurourol Urodyn 40(1):28–37. https://doi.org/10.1002/nau.24536CrossRefPubMed

25.

Bottet F, Peyronnet B, Boissier R, Reiss B, Previnaire JG, Manunta A, Kerdraon J, Ruffion A, Lenormand L, PerrouinVerbe B, Gaillet S, Gamé X, Karsenty G (2018) Groupe d’Etude de Neuro-Urologie de Langue Française and the committee of NeuroUrology of the French Association of Urology [AFU]. Switch to Abobotulinum toxin A may be useful in the treatment of neurogenic detrusor overactivity when intradetrusor injections of Onabotulinum toxin A failed. Neurourol Urodyn 37(1):291–297. https://doi.org/10.1002/nau.23291CrossRefPubMed

26.

Giannantoni A, Gubbiotti M, Rubilotta E, Balzarro M, Antonelli A, Bini V (2022) IncobotulinumtoxinA versus onabotulinumtoxinA intradetrusor injections in patients with neurogenic detrusor overactivity incontinence: a double-blind, randomized, non-inferiority trial. Minerva Urol Nephrol 74(5):625–635. https://doi.org/10.23736/S2724-6051.21.04227-2CrossRefPubMed

27.

Wang X, Zhang F, Liao L (2021) Current applications and future directions of bioengineering approaches for bladder augmentation and reconstruction. Front Surg 8:664404. https://doi.org/10.3389/fsurg.2021.664404CrossRefPubMedPubMedCentral

28.

Dinh A, Davido B, Duran C, Bouchand F, Gaillard JL, Even A, Denys P, Chartier-Kastler E, Bernard L (2019) Urinary tract infections in patients with neurogenic bladder. Med Mal Infect 49(7):495–504. https://doi.org/10.1016/j.medmal.2019.02.006CrossRefPubMed

29.

Poirier C, Dinh A, Salomon J, Grall N, Andremont A, Bernard L (2016) Prevention of urinary tract infections by antibiotic cycling in spinal cord injury patients and low emergence of multidrug resistant bacteria. Med Mal Infect 46(6):294–299. https://doi.org/10.1016/j.medmal.2016.02.010CrossRefPubMed

30.

Cox L, He C, Bevins J, Clemens JQ, Stoffel JT, Cameron AP (2017) Gentamicin bladder instillations decrease symptomatic urinary tract infections in neurogenic bladder patients on intermittent catheterization. Can Urol Assoc J 11(9):E350–E354. https://doi.org/10.5489/cuaj.4434CrossRefPubMedPubMedCentral

31.

Zillioux JM, Jackson JN, Herndon CDA, Corbett ST, Kern NG (2018) Caring for urological transition patients: current practice patterns and opinions. J Pediatr Urol. 14(3):242.e1-242.e5. https://doi.org/10.1016/j.jpurol.2018.02.007CrossRefPubMed

32.

Bower WF, Christie D, DeGennaro M, Latthe P, Raes A, Romao RL, Taghizadeh A, Wood D, Woodhouse CR, Bauer SB (2017) The transition of young adults with lifelong urological needs from pediatric to adult services: An international children’s continence society position statement. Neurourol Urodyn 36(3):811–819. https://doi.org/10.1002/nau.23039CrossRefPubMed

33.

Eswara JR, Kielb S, Koyle MA, Wood D, Wood HM (2015) The recommendations of the 2015 American Urological Association Working Group on genitourinary congenitalism. Urology 88:1–7. https://doi.org/10.1016/j.urology.2015.11.019CrossRefPubMed

34.

Del Popolo G, Antonucci L (2020) Disability and sustainability: reusable versus single-use catheters for persons with neurogenic bladder due to spinal cord injury. Spinal Cord Ser Cases 6(1):90. https://doi.org/10.1038/s41394-020-00340-yCrossRefPubMedPubMedCentral

Titel: Unmet needs in the management of neurourological disorders within the last 50 years
verfasst von: Amélie Bazinet
Emmanuel Chartier-Kastler
Publikationsdatum: 02.11.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: World Journal of Urology / Ausgabe 12/2023
Print ISSN: 0724-4983
Elektronische ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-023-04662-y

Neu im Fachgebiet Urologie

Hypertherme Chemotherapie bietet Chance auf Blasenerhalt

07.05.2024 Harnblasenkarzinom Nachrichten

Eine hypertherme intravesikale Chemotherapie mit Mitomycin kann für Patienten mit hochriskantem nicht muskelinvasivem Blasenkrebs eine Alternative zur radikalen Zystektomie darstellen. Kölner Urologen berichten über ihre Erfahrungen.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Medizinstudium Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Männern mit Zystitis Schmalband-Antibiotika verordnen

03.05.2024 Zystitis Nachrichten

Die akute Zystitis von Männern und ihre Therapie sind wenig erforscht. Norwegische Forscher haben das nachgeholt. Ihr Rat: Erst einmal keine Breitbandantibiotika verordnen.

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

02.05.2024 Prostatakarzinom Nachrichten

Eine adjuvante Radiotherapie nach radikaler Prostata-Op. bringt den Betroffenen wahrscheinlich keinen Vorteil. Im Gegenteil: Durch die Bestrahlung steigt offenbar das Risiko für Harn- und Stuhlinkontinenz.

Update Urologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Bildnachweise

Operation bei Blasenkrebs/© anistidesign / Fotolia, Medizinische Fachangestellte sitzt erschöpft auf der Treppe/© Courtney Haas / peopleimages.com /stock.adobe.com (Symbolbild mit Fotomodell), Glomerulationen bei interstitieller Zystitis/© Tolle, J., Kaftan, B.T. & Bschleipfer, T. / all rights reserved Springer Medizin Verlag GmbH, Darstellung der Dosisverteilung bei Bestrahlung eines Prostatakarzinoms/© Degener, S et al. / all rights reserved Springer Medizin Verlag GmbH

Springer Medizin

Abstract

Purpose

Methods

Result

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 12/2023

Comparison of traditional and novel tip-flexible suctioning ureteral access sheath combined with flexible ureteroscope to treat unilateral renal calculi

A US real-world study of treatment patterns and outcomes in localized or locally advanced prostate cancer patients

Does the urinary microbiome profile change after treatment of bladder cancer?

Design and rationale of a single-arm phase II study of neoadjuvant Durvalumab and Gemcitabine associated with Cisplatin or Carboplatin for upper urinary tract urothelial cancer: the iNDUCT trial (NCT04617756)

Benign prostatic hyperplasia burden comparison between China and United States based on the Global Burden of Disease Study 2019

Comparison of EEP and TURP long-term outcomes: systematic review and meta-analysis